Sponsors
2
Speakers
1
Attendees
150
A healthcare conference focused on the latest data and treatment strategies for ALK-positive non-small cell lung cancer (NSCLC). It covers practice-changing insights, sequencing approaches, toxicity management, and integration of novel targeted therapies into clinical care.
MD
Keck School of Medicine of USC
💡 Looking for sponsorship opportunities? Our platform provides detailed sponsor contact information and pricing data to help you make informed partnership decisions.